π Simple Summary
Indole-3-propionic acid β IPA for short β is a molecule your own gut bacteria make when they break down tryptophan, a building block of protein. You can’t get meaningful amounts of it from food; you get it by feeding the right bacteria enough fiber. Higher blood levels of IPA are consistently linked to a lower risk of type 2 diabetes, and a 2026 study found it extended the lifespan of fruit flies and strengthened muscle and bone in older mice. It works partly by acting as a powerful antioxidant and by tightening the lining of your gut. The catch: there are no human trials yet showing that taking IPA as a supplement slows aging, so the excitement is real but the proof is still building.
What if the secret to slower aging wasn’t a pill, but something your own gut bacteria already make β and you just stopped feeding them? Indole-3-propionic acid is one of the most intriguing “postbiotics” in longevity research right now: a tryptophan metabolite produced by gut microbes that acts as a stronger free-radical scavenger than melatonin, tightens the gut barrier, and β in a 2026 GeroScience study β extended lifespan in flies while rebuilding muscle and bone in aged mice. Here’s what’s real, what’s promising, and what’s still unproven.
Evidence Tier: π₯ Silver β strong mechanism, consistent human observational data, and first direct animal lifespan evidence, but no human supplementation trials yet.
βοΈ At a Glance: Pros & Cons
β οΈ We are researchers, not doctors. Nothing on this page is medical advice. IPA is not a substitute for treating diabetes, liver disease, or any other condition, and it has no long-term human safety record. Always talk to your doctor before adding any supplement.
β Pros
- Strongest signal: Higher blood IPA is consistently linked to a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study and two independent replication cohorts.
- First direct longevity data: A 2026 study found IPA extended fruit-fly lifespan and improved grip strength and bone microarchitecture in aged mice.
- Potent antioxidant: IPA scavenges hydroxyl radicals more effectively than melatonin β without melatonin’s pro-oxidant rebound effect.
- Gut-barrier support: IPA activates the PXR receptor, which tightens the intestinal lining and counters “leaky gut.”
β Cons
- No human trials: Zero randomized controlled trials have tested IPA supplementation for longevity or aging outcomes in people.
- Not something you can eat: IPA is made by specific gut bacteria; you can’t reliably raise it just by taking tryptophan or eating more protein.
- Cancer caution: One 2026 study found IPA promoted lymph-node spread in gastric cancer via the AhR receptor β its effects are context-dependent, not universally good.
- Unregulated supply: Commercial IPA is essentially a research chemical; purity, sourcing, and dosing are not standardized or FDA-reviewed.
What Is Indole-3-Propionic Acid?
Indole-3-propionic acid (IPA) is a small molecule in the “indole” family, structurally similar to the sleep hormone melatonin. Your body does not make it β instead, certain bacteria that live in your large intestine (most famously Clostridium sporogenes) build it from tryptophan, an amino acid you get from eating protein.
Once the bacteria produce it, IPA crosses into your bloodstream and circulates throughout your body, including into your brain across the blood-brain barrier. Because it is made by microbes rather than by your own cells, IPA is called a postbiotic β a beneficial compound that your gut bacteria manufacture for you.
The amount of IPA in your blood depends far more on the composition of your gut microbiome and your fiber intake than on how much tryptophan you eat. This is why two people eating identical diets can have very different IPA levels.
How It Works
IPA appears to act through several overlapping mechanisms, which is part of why it has attracted longevity researchers:
- Antioxidant and free-radical scavenger. In 1999, researchers showed IPA protected neurons against oxidative damage and β in head-to-head kinetic tests β scavenged hydroxyl radicals more effectively than melatonin, long considered the body’s most potent natural scavenger. Unlike many antioxidants, IPA does not flip into a damaging “pro-oxidant” state while doing its job.
- Gut-barrier tightening via PXR. A landmark 2014 Immunity study showed IPA is a natural activator of the PXR receptor (pregnane X receptor), a sensor that, when switched on, strengthens the junctions between intestinal cells. Mice lacking this receptor developed a “leaky” gut.
- AhR (aryl hydrocarbon receptor) signaling. IPA also activates the AhR receptor, which helps regulate inflammation, lipid metabolism, and immune function. This same pathway is a double-edged sword β see the cancer caution below.
- Lowering inflammation. In human data, higher IPA tracks with lower levels of hsCRP, a blood marker of low-grade inflammation that rises with age.
The Longevity Connection
Here is where the evidence actually stands, broken down by outcome:
- Lifespan (preclinical). A 2026 GeroScience study β the most direct longevity evidence to date β fed fruit flies IPA and found a significant lifespan extension, though the effect depended on the flies’ genetics and sex. In the same paper, aged mice given IPA showed better muscle function and stronger bones. A related compound (indolepropionamide) extended rotifer lifespan back in 2010.
- Muscle and bone. In aged mice, 12 weeks of IPA improved grip strength and “hang time” and enhanced bone microarchitecture β though muscle fiber size was unchanged, suggesting the benefit is more about function and cellular survival than raw growth. Two 2026 studies also report IPA rescues osteoporosis by nudging bone-marrow stem cells away from fat and toward bone.
- Metabolic health and diabetes. The strongest human evidence. Higher blood IPA was associated with a lower risk of developing type 2 diabetes in the Finnish Diabetes Prevention Study (discovery) and replicated in Finnish and Swedish cohorts. A follow-up quantitative study found each step up in IPA tracked with roughly 14% lower diabetes risk (odds ratio 0.86), and IPA correlated positively with fiber intake and negatively with inflammation.
- Liver. Multiple 2025β2026 studies report IPA protects against fatty liver (NAFLD/MASLD) by improving mitochondrial cleanup and reducing liver-cell stress, and lower IPA has been linked to liver fibrosis.
- Brain. IPA’s neuroprotection against amyloid-beta β the protein that clumps in Alzheimer’s disease β was the finding that launched interest in it back in 1999, and it was once developed under the name “OXIGON” as a potential Alzheimer’s therapy.
Key Studies
| Study | Design | Key Finding |
|---|---|---|
| Vyavahare 2026 (GeroScience) | Aged mice + fruit flies | IPA extended fly lifespan and improved muscle function and bone in aged mice |
| Chyan 1999 (J Biol Chem) | Cell / neuron studies | IPA protected neurons from amyloid-beta; scavenged hydroxyl radicals better than melatonin |
| Venkatesh 2014 (Immunity) | PXR knockout mice | IPA activates PXR to tighten the gut barrier |
| de Mello 2017 (Sci Rep) | Human cohort (nβ200) | Higher IPA linked to lower type 2 diabetes risk; replicated in two more cohorts |
| Tuomainen 2018 (Nutr Diabetes) | Human cohort (n=415) | Odds ratio 0.86 for diabetes; IPA tracked fiber intake and lower inflammation |
| Poeggeler 2010 (PLoS One) | Rotifer lifespan | Related compound indolepropionamide extended rotifer lifespan |
Dosing and Safety
There is no established human dose for IPA. This is the single most important thing to understand. IPA has never been through a human supplementation trial, so any dose you see marketed is a guess, not a finding.
- Animal dose (not directly translatable): The 2026 GeroScience study gave aged mice 20 mg/kg by injection three times a week. Mice metabolize compounds very differently from people, so this does not convert to a human pill dose.
- Natural route (the evidence-backed option): The only well-supported way to raise IPA is to feed the bacteria that make it β higher dietary fiber intake is consistently linked to higher IPA levels. This is free and has zero risk.
- Supplement form: IPA is sold as a powder/research chemical by a handful of vendors. Purity is not independently verified, and there are no long-term human safety data.
- Side effects: No serious side effects have been reported in the short-term animal studies, but that is not the same as a clean safety record β it simply has not been studied in humans long-term.
π¦ What This Means for Your Microbiome
IPA is one of the clearest examples of your gut bacteria working for you. The bacteria that make it β Clostridium sporogenes and a few others β only produce meaningful amounts when you feed them fiber. A high-fiber diet, rich in legumes, whole grains, and vegetables, is the most reliable way to raise your IPA. This is one reason the “eat more fiber” advice keeps showing up in longevity research: it is, in part, an instruction to feed the bacteria that make IPA.
β Common Questions About Indole-3-Propionic Acid
What is indole-3-propionic acid and how does it work?
Indole-3-propionic acid (IPA) is a molecule your gut bacteria make from tryptophan, an amino acid in protein. It works as a strong antioxidant that mops up damaging free radicals, and it switches on receptors (PXR and AhR) that tighten the gut lining and calm inflammation.
What does the evidence actually show?
The evidence is promising but early (Silver tier). Higher blood IPA is consistently linked to lower diabetes risk in human studies, and a 2026 study found it extended fly lifespan and helped muscle and bone in aged mice. But there are no human trials yet showing that taking IPA as a supplement slows aging.
What’s the right dose?
There is no established human dose. Animal studies used roughly 20 mg/kg in mice, which does not translate to a human pill. The most reliable way to raise IPA is not a supplement at all β it’s eating more fiber, which feeds the bacteria that make it.
What are the risks and side effects?
Short-term animal studies report few side effects, but IPA has no long-term human safety record. One caution: a 2026 study found IPA promoted cancer spread in gastric cancer through the AhR receptor, so its effects are not universally protective.
Who should avoid it?
Anyone who is pregnant or breastfeeding, anyone with a history of cancer (especially stomach or gastrointestinal cancers), and anyone taking immune-modulating medications should avoid IPA supplements, given the lack of safety data and the cancer-context concern. Always check with a doctor first.
The Bottom Line
Indole-3-propionic acid is a genuinely exciting molecule β a gut-made postbiotic with a clean mechanistic story (antioxidant stronger than melatonin, gut-barrier tightening, anti-inflammatory), consistent human observational data linking it to lower diabetes risk, and the first direct animal lifespan evidence. That combination earns it π₯ Silver.
But “Silver” means the anti-aging claims are still preclinical. No one has shown that swallowing IPA pills extends human lifespan or even improves a hard health outcome in people. The honest takeaway: if you want more IPA, the proven move is free β eat more fiber and take care of your gut bacteria. Save the IPA supplements for after human trials exist.
Who it’s for: People focused on gut health and metabolic prevention who want to understand an emerging postbiotic. Who it’s not for: Anyone looking for a proven anti-aging pill, or anyone with a cancer history.
Medical Disclaimer: This article is for educational purposes only and is not medical advice. Indole-3-propionic acid is not approved by the FDA to treat or prevent any disease. Supplements can interact with medications and affect health conditions. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication. Full disclaimer β
Sources
- Vyavahare S, et al. Microbiota-derived indole-3-propionic acid extends lifespan in Drosophila and improves muscle and bone health in mice. GeroScience. 2026. PMID 41540161
- Chyan YJ, et al. Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J Biol Chem. 1999. PMID 10419516
- Karbownik M, et al. Relative efficacies of indole antioxidants in reducing autoxidation and iron-induced lipid peroxidation in hamster testes. J Cell Biochem. 2001. PMID 11329624
- Karbownik M, et al. Carcinogen-induced, free radical-mediated reduction in microsomal membrane fluidity: reversal by indole-3-propionic acid. J Bioenerg Biomembr. 2001. PMID 11460928
- Venkatesh M, et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity. 2014. PMID 25065623
- Bendheim PE, et al. Development of indole-3-propionic acid (OXIGON) for Alzheimer’s disease. J Mol Neurosci. 2002. PMID 12212784
- de Mello VD, et al. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study. Sci Rep. 2017. PMID 28397877
- Tuomainen M, et al. Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals. Nutr Diabetes. 2018. PMID 29795366
- Sehgal R, et al. Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease. Nutrients. 2022. PMID 36364957
- Agus A, et al. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe. 2018. PMID 29902437
- Poeggeler B, et al. A novel endogenous indole protects rodent mitochondria and extends rotifer lifespan. PLoS One. 2010. PMID 20421998
- Engineered probiotic-derived indole-3-propionic acid inhibits ubiquitination via AHR signaling to treat postmenopausal osteoporosis. Gut Microbes. 2026. PMID 41508814
- Microbiota-derived indole-3-propionic acid reprograms bone marrow stem cell fate via PPARΞ³ suppression to rescue osteoporosis. Int J Mol Sci. 2026. PMID 42246175
- Indole-3-propionic acid promotes hepatic stellate cells inactivation. J Transl Med. 2025. PMID 40025530
- Indole-3-Propionic Acid Alleviates Metabolic Dysfunction-Associated Fatty Liver Disease via AHR/AMPK Signaling Activation. Food Sci Nutr. 2026. PMID 42569087
- Microbiota-derived Indole-3-propionic acid improves FFA-induced liver injury in an in vitro model of nonalcoholic fatty liver disease by activating PINK1. Toxicol In Vitro. 2026. PMID 42486310
- Nieves KM, et al. Indole-3-propionic acid protects medium-diversity colitic mice via barrier enhancement preferentially over anti-inflammatory effects. Am J Physiol Gastrointest Liver Physiol. 2025. PMID 40257386
- Gut microbiota-derived indole-3-propionic acid promotes lymph node metastasis in gastric cancer via the aryl-hydrocarbon receptor signaling pathway. Cancer Metab. 2026. PMID 42163413